.svg){kind=small}
Apr-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the state of Ohio, Remidose made a notable entrance in the Tincture & Sublingual category at the beginning of 2025. Ranking 8th in January, the brand showcased a promising start with sales figures reaching a respectable amount. However, the absence of rankings in subsequent months suggests that Remidose might have faced challenges in maintaining its initial momentum. This drop-off from the top 30 could indicate increased competition or a shift in consumer preferences within the Ohio market.
While Remidose's initial performance in Ohio is commendable, the lack of data for February through April raises questions about its strategy and market presence. The initial ranking in January indicates potential, but sustaining such performance appears to be a hurdle. Understanding the dynamics that led to their January success and subsequent decline could provide valuable insights into the brand's operations and market adaptability. As Remidose continues to navigate the competitive landscape, monitoring future movements will be crucial to assess whether they can regain their footing in Ohio's cannabis market.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in Ohio, Remidose has experienced notable shifts in its market presence. Starting in January 2025, Remidose held the 8th rank, but it did not appear in the top 20 for the subsequent months, indicating a significant drop in its competitive standing. In contrast, Standard Farms maintained a consistent presence, ranking 6th in February and gradually dropping to 8th by April, while Avexia consistently held the 4th position throughout the same period. This suggests that while Remidose initially had a foothold in the market, it struggled to sustain its position against competitors who have shown more stability or growth. The data implies that Remidose may need to reassess its strategies to regain visibility and sales momentum in this competitive category.
Notable Products
In April 2025, Remidose's top-performing product was the Berry Sublingual Oral Spray (500mg) from the Tincture & Sublingual category, maintaining its number one rank consistently from March. The Grape Sublingual Oral Spray (500mg) followed closely in second place, experiencing a slight improvement from its third-place ranking in February. The Strawberry Sublingual Oral Spray (500mg) held steady in the third position for the month, showing a notable increase from its sales figure of 64 units. Citrus Live Resin Drops Oil (30ml) ranked fourth, dropping from its second-place position in March, while the Pomegranate Sublingual Oral Spray (500mg) remained consistently in fifth place across the months. This analysis highlights the strong performance and stability of Remidose's sublingual products over the months leading up to April 2025.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
